Joint solution will allow live telehealth care to be rendered to patients at home, incorporating biometric information, increasing the feasibility and efficacy of remote monitoring
Boston, Mass., February 22, 2012 — Accelerating efforts to improve and expand access to high quality care, Joslin Diabetes Center and American Well™ today announced their intent to collaborate in order to bring telehealth services to patients nationwide, powered by American Well’s Online Care technology.
Joslin Diabetes Center has begun a technology initiative which will improve the lives of people with diabetes and its complications through innovative care, education and research. Through technology and telehealth delivery, the expertise gained over a century of diabetes care will be shared with clinical environments across the state, across the country and around the world. Joslin intends to introduce this initiative with the goal of improving clinical and financial outcomes. In the coming months, Joslin and American Well will work together to bring this telehealth initiative forward.
“Joslin Diabetes Center is committed to fundamentally changing the landscape of diabetes care today,” said John L. Brooks III, president and chief executive officer of Joslin Diabetes Center. “Telehealth provides an opportunity to bring together our strengths in research, clinical care, education and awareness in order to create an entirely new class of clinical program – then project care directly to the patients who need it most, at the appropriate time. With American Well, we look forward to applying a transformative healthcare innovation in support of our mission of improving the lives of people struggling with this disease.”
“We look forward to joining with Joslin Diabetes Center to help combat a disease that burdens the lives of countless families and, increasingly, our society as a whole,” said Ido Schoenberg, MD, chairman and CEO, American Well, Inc. “Joslin is enlisting telehealth in one of its most powerful forms – as a conduit for delivering tailor-made clinical programs to patients who might not otherwise have access to them.”
About Joslin Diabetes Center
Joslin Diabetes Center, a teaching and research affiliate of Harvard Medical School, is a one-of-a-kind institution on the front lines of the world epidemic of diabetes — leading the battle to conquer diabetes in all of its forms through cutting-edge research and innovative approaches to clinical care and education. At Joslin, every person is dedicated to realizing our vision of a world without diabetes and its complications through a relentless pursuit of our mission: To improve the lives of people with diabetes and its complications through innovative care, education, and research that will lead to prevention and cure of the disease.